At 17.42% CAGR, Oligonucleotide Synthesis Market Size is Expected to Reach USD 22584.1 Million in 2028, says Brandessence Market Research

LONDON, Jan. 17, 2022 /PRNewswire/ -- The Global Oligonucleotide Synthesis Market is valued at USD 7338.5 Million in 2021 and is expected to reach USD 22584.1 Million by 2028 with a CAGR of 17.42% over the forecast period. Increasing government investments for synthetic biology & genome projects and soaring need for oligo products are some of the major factors driving the growth of the Global Oligonucleotide Synthesis Market By Brandessence Market Research & Consulting Pvt ltd.

The Brandessence research team has thoroughly observed the impact of Covid-19 on the global oligonucleotide synthesis market, and it is perceived that the demand for oligonucleotide synthesis has augmented throughout the pandemic time. To control the overwhelming spread of Covid-19, numerous countries throughout the globe have enforced severe lockdown norms, which have hindered many kinds of business activities. However, there has also been a constructive effect and outpouring in demand for several medical services, comprising oligonucleotide products. The many players of the oligonucleotide synthesis market are stepping frontward to contribute to worldwide research efforts by offering oligo products for developing treatments, test kits, and vaccines.

Get Sample Copy of This Premium Report@ https://brandessenceresearch.com/requestSample/PostId/1816

Scope of Global Oligonucleotide Synthesis Market Report:

Oligonucleotides are short RNA or DNA molecules, oligomers that are used as probes for noticing precise sequences that are complementary to the oligonucleotides. Oligonucleotides have an extensive range of applications in research, genetic testing, and forensics. Oligonucleotide synthesis is the synthesis of moderately small fragments of nucleic acids performed chemically with a defined chemical structure (sequence). This technique delivers speedy and inexpensive access to custom-made oligonucleotides of the preferred sequence. Oligonucleotide synthesis is also useful for carrying out the molecular diagnosis in numerous diseases, counting detection of infectious diseases, such as SARS-COV2, hepatitis, as well as for diagnosis of cancer. These are generally used in laboratories in various applications such as diagnostics, therapeutic, academic, as well as industrial. These are used from early research and screening over to target validation and drug manufacture. Nowadays, number of improvements in oligonucleotide synthesis, automation, and amplification have totally revolutionized biological research. It is also possible to do the customizations and get the desired sequence online effortlessly and at the obligatory time. In the initial 1950s, Alexander Todd's group established H-phosphonate and phosphate triester approaches of oligonucleotide synthesis.

Global Oligonucleotide Synthesis Market Dynamics:

The surge in demand for oligo products for the treatment of Covid-19 is one of the major factors enhancing the growth of the oligonucleotide synthesis market. The outbreak of Covid-19 has disrupted workflows in the healthcare segment throughout the world. Nevertheless, there has also been an optimistic effect and increase in demand for many medical services, containing oligonucleotide products. The oligo products are majorly used for improving the treatments, test kits, and vaccines which target the novel Coronavirus infection. In addition, with the increase in the cases of coronavirus disease, new generations of oligonucleotide drugs, including mRNA and DNA vaccines, are currently under development. Besides, with the intensification in cases of coronavirus disease and the urgency for a prospective treatment, new generations of oligonucleotide drugs, containing mRNA and DNA vaccines, are presently under progress. For instance; in April 2020, for Covid-19 vaccine progress, TriLink BioTechnologies signed a partnership with Imperial College London for the manufacturing of self-amplifying RNA (saRNA) and also brought ready-to-use cocktail mixes such as the SARS-CoV-2 N2 Oligo Mix, the SARS-CoV-2 N1 Oligo Mix, and the Human RNase P (RP) Oligo Mix for Covid-19 research.

Furthermore, governments in numerous countries have made noteworthy investments in projects associated with the field of synthetic biology and genomics. These government investments have played a chief role in the enlargement of innovative technologies. Oligos play a vital role in these technologies, and thus, the rising funding & improvements in these fields is also fostering  the market growth. For example; the Department of Biotechnology (DBT) originated the "Genome India Project" in January 2020. This scheme purposes to gather around 10,000 genetic samples from citizens through India to build a reference genome. In addition to this, in the UK, the Centre for Process Innovation launched a project in the Medicines Manufacturing Innovation Centre in February 2021. This scheme targets to revolutionize the engineering of oligonucleotides over collaboration with Novartis, AstraZeneca, Exactmer, and the UK Research & Innovation. Such ongoing government-sponsored projects will lead to enhancements in genomic technologies, precisely in DNA sequencing, DNA amplification, NGS, and gene expression. Consequently, this factor is playing the main role in the growth of the oligonucleotide synthesis market.

Some of the key players for global Oligonucleotide Synthesis are:

• Alnylam Pharmaceuticals, Inc.
• Biogen Inc.
• Danaher Corporation
• Eurofins Scientific
• Ionis Pharmaceuticals, Inc.
• Kaneka Corporation
• LGC Limited
• Merck KGAA
• Sarepta Therapeutics, Inc.
• Thermo Fisher Scientific, Inc.
• Others are also Contributing on Oligonucleotide Synthesis Market 

News: Biotage Acquired DNA Synthesis and Purification Company ATDBio

On October 20th, 2021- Biotage, a Swedish analytics and drug discovery company, arrived into an agreement to acquire shares in UK based ATDBio Limited (ATDBio), for a total price of roughly £45 million. ATDBio enhances significant platform solutions to Biotage within DNA and RNA oligonucleotide synthesis and purification. The acquisition is projected to strengthen Biotage as a prominent life science tool and impact tech service provider.

Get Methodology @ https://brandessenceresearch.com/requestMethodology/PostId/1816

Oligonucleotide Synthesis Key Segmentation Analysis:

By product:

• Oligonucleotide-based Drugs
• Synthesized Oligonucleotides
• Reagents
• Equipment

By Applications:

• Therapeutic Applications
• Research Applications
• Diagnostic Applications

By End-users:

• Hospitals
• Pharmaceutical & Biotechnology Companies
• Diagnostic Laboratories
• CROs and CMOs
• Academic Research Institutes

By Disease Type:

• Neurological Disorders
• Infectious Diseases
• Other Diseases

Global Oligonucleotide Synthesis Market Regional Analysis:

Geographically, North America is expected to account for the largest share in the global oligonucleotide synthesis market within the forecast period attributed to the increasing R&D in life sciences, rising focus on improving the safety & quality of healthcare, and many other factors. The presence of numerous global players in this region is the leading key factor contributing to this market segment. Danaher Corporation, Thermo Fisher Scientific, Inc., Maravai Life Sciences, and many more players are pouring millions into the oligonucleotide synthesis market. Apart from these, the number of small and mid-sized players are also leveraging in this market. For example; on July 29th, 2019; Twist Bioscience Corporation announced the launch of its long oligonucleotides. Withal, Biotage Company acquired UK-based Oligo Maker ATDBio for £45M in Cash, Stock on October 20th, 2021. Many other companies which are not even from the U.S. have a huge presence in the U.S. Similarly, many players from the oligonucleotide synthesis market have largely expanded their business in this region. So, this is intensively boosting the market growth of oligonucleotide synthesis.

Also, Asia Pacific is the fastest-growing region in the oligonucleotide synthesis market owing to an upsurge in cases of chronic disorders such as Covid-19, coronary disease, cancer, and others. For example; in accordance with World Cancer Research Fund; the highest cancer rate in South Korea for men and women together was 313.5 people per 100,000. Furthermore, according to Worlometer, on January 10, 2022, Asia pacific reported more than 86,888,347 total cases of Covid-19 of which nearly 1,263,870 cause death. As the prevalence of the number of chronic diseases is growing day by day, the need for treatment is significantly enhancing with it. Significantly, the oligonucleotide is an emerging therapeutic modality for several common diseases like Covid-19, coronary disease. Therefore, the market value for oligonucleotide synthesis is booming in this region and making the Asia Pacific the fastest growing region all over the globe.

On Special Requirement Oligonucleotide Synthesis Market Report is also available for below region:

North America

• U.S, Canada

Europe

• Germany, France,U.K., Italy, Spain, Sweden, Netherland, Turkey, Switzerland, Belgium, Rest of Europe

Asia-Pacific

• South Korea, Japan, China, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest Of APAC,

Latin America

• Mexico, Colombia, Brazil, Argentina, Peru, Rest of Latin America

Middle East and Africa

• Saudi Arabia, UAE, Egypt, South Africa, Rest Of MEA

Get Full Access of all Report: https://brandessenceresearch.com/chemical-and-materials/oligonucleotide-synthesis-market

Related Reports At Bellow:

• The Global Building Information Modeling Market to hit USD 18.73 Billion by 2028
• Personal Emergency Response Systems Market Expected to Reach USD 8.20 Billion, globally by 2028
• The Supercapacitors Market Size to hit USD 22.50 Billion in 2028
• The Solar Panels Market size Expected to Reach USD 902.55 Bn, Globally by 2028
• Global Video Conferencing Market Size to hit USD 10.20 Billion to 2028
• Nitrile Gloves Market size is Expected to Reach USD 14.08 Billion, globally by 2028
• Acne Treatment Market Anticipated to Reach 19.03 Billion by 2028
• Global Plating On Plastics Market Expected to Reach USD 1044.46 Million, globally by 2028
• Hydrogen Generators Market Size to hit USD 1973.8 Million by 2028
• Europe ADAS Market Global Demand Analysis to 2028
• US In-Car Infotainment Market Trends and Analysis on Automotive Demand
• India EV Charger Market Demand Is Growing Due to High Demand E-Vehicle
• Global 3D Animation Market Size to hit USD 32.87 Billion to 2028

i-Factor: Live Market intelligence platform

I-Factor is our guaranteed seal to keep our clients ahead of the competition, always. This knowledge platform delivers real-time updates on key economic indicators, competitive landscape, changing demand, trends, customized regional insights, and more. The platform visualizes key data points to help make decision making agile, trustworthy, and holistic. Register for free trail here @ https://brandessenceresearch.com/i-factor/login/userRegister

Brandessence Market Research & Consulting Pvt ltd.

Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

Website: https://brandessenceresearch.com 
Blog:  Healthcare Staffing Global Companies
Follow Us: LinkedIn

Mr. Vishal Sawant 
Email: [email protected] 
Email: [email protected] 
Corporate Sales: +44-2038074155
Asia Office: +917447409162

SOURCE Brandessence Market Research And Consulting Private Limited